Zepbound 5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FMYYW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,481
Award facts
- Contract value 100% obligated
- $2,480.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $2,480.68 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pen injectors on August 27, 2025. This firm fixed price, competitively awarded delivery order represents a single transaction under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 28, 2025. No set-aside designation was applied to this award.
This delivery order is a child contract issued under AmerisourceBergen Drug Corp's comprehensive $999,999,999.00 Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which extends through December 2026 and serves as a global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, has established itself as a critical federal medical procurement vendor through its extensive portfolio of competitively awarded contracts supplying brand-name and generic medications, vaccines, and specialized healthcare commodities to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Zepbound, a GLP-1 receptor agonist used in diabetes and weight management treatment, aligns with the company's demonstrated capability to supply specialty medications across multiple therapeutic domains to support military and federal healthcare needs.
Quick answers
Who was awarded contract SPE2DB25FMYYW?
SPE2DB25FMYYW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 27, 2025.
How much is contract SPE2DB25FMYYW worth?
The government has obligated $2,481 on SPE2DB25FMYYW.
Is contract SPE2DB25FMYYW an order under another contract?
Yes. SPE2DB25FMYYW is a delivery order under SPE2DB20D2104, an indefinite delivery contract.
Was contract SPE2DB25FMYYW competed?
The extent of competition for SPE2DB25FMYYW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award